SOURCE: DPx Holdings

Patheon

November 20, 2014 10:00 ET

DPx Holdings Appoints Eric M. Sherbet as General Counsel

DURHAM, NC--(Marketwired - November 20, 2014) - DPx Holdings B.V. (DPx), owners of pharmaceutical services provider Patheon, DPx Fine Chemicals and Banner Life Sciences, today announced the appointment of Eric M. Sherbet as the new general counsel and secretary. Sherbet will report directly to James C. Mullen, chief executive officer for DPx Holdings, and will be based at the company's Boston offices.

"We are happy to have Eric join the organization and expect his previous experience to benefit the organization going forward," said Mullen. "He has a solid track record of helping a diverse set of companies during periods of rapid growth and serving as a trusted advisor to management and Boards of Directors."

In his new role, Sherbet will be responsible for all global legal affairs, corporate compliance and regulatory matters, and serve as secretary for the company's Board of Directors. He brings more than 25 years of experience to the organization, representing global public and private equity backed companies in the pharmaceutical, professional services, engineering and construction and telecommunication sectors.

"It is a great time to be joining the senior leadership team at DPx Holdings, an organization focused on providing outstanding service and support to customers and a recognized leader in the global marketplace," said Sherbet. 

Sherbet most recently served as general counsel and secretary for inVentiv Health, Inc., where he built the legal and compliance department to support various business concerns, including mergers and acquisitions (M&A), SEC filings, compliance and regulatory issues, and commercial deals. 

Prior to his role at inVentiv Health, Sherbet served in senior legal positions with Foster Wheeler, a global engineering and construction organization and Avaya Inc., a global provider of communications systems, software and services. Earlier in his career, Sherbet represented both public and private companies in private practice specializing in M&A, debt and equity offerings and compliance and reporting. 

He holds a Bachelor of Science in commerce from the University of Virginia and a Juris Doctor from the New York University School of Law.

About DPx Holdings B.V.
DPx Holdings B.V. is parent company of the Patheon, DPx Fine Chemicals and Banner Life Sciences businesses. The company offers customers unsurpassed quality, end-to-end solutions and value through its three business units. DPx Holdings is a leading provider of CDMO services, pharmaceutical products and other formulated products for various industries. The company was formed in 2014 as a result of the merger of Patheon and DSM Pharmaceutical Products and is owned by JLL Partners and Royal DSM. With a global headquarters in Durham, N.C., DPx Holdings B.V. has a footprint of more than 20 locations across North America, Europe, Latin America and Australia with more than 8,000 employees. For more information, visit www.patheon.com/DPx.

Contact Information